Clinical trial
Combination Chemotherapy With Suramin Plus Doxorubicin in Treating Patients With…
NCT00003038 · Mayo Clinic, Other · Completed
Key facts
| NCT number | NCT00003038 |
|---|---|
| Title | Combination Chemotherapy With Suramin Plus Doxorubicin in Treating Patients With Advanced Solid Tumors |
| Official title | A Phase I Trial of Suramin With Sequential Doxorubicin in Patients With Advanced Solid Tumors |
| Lead sponsor | Mayo Clinic, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Adrenocortical Carcinoma, Breast Cancer, Colorectal Cancer, Prostate Cancer, Unspecified Adult Solid Tumor, Protocol Specific |
| Intervention type | Drug |
| Interventions | doxorubicin hydrochloride, suramin |
| Start date | Oct 1, 1997 |
| Primary completion | Jan 1, 2003 |
| Completion | Jan 1, 2003 |
| First posted | Apr 30, 2004 |
| Last update posted | Aug 3, 2011 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: